- Home
- YCBD vs OSRH Comparison
YCBD vs OSRH Comparison
Compare YCBD & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YCBD | OSRH |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5M | 14.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | YCBD | OSRH |
|---|---|---|
| Price | $1.68 | $0.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 32.2M | 721.5K |
| Earning Date | 12-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,190,468.00 | N/A |
| Revenue This Year | $0.37 | N/A |
| Revenue Next Year | $4.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.47 | $0.45 |
| 52 Week High | $6.54 | $12.54 |
Technical Indicators
Market Signals| Indicator | YCBD | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 62.06 | 51.02 |
| Support Level | $1.31 | $0.56 |
| Resistance Level | $1.82 | $0.69 |
| Average True Range (ATR) | 0.34 | 0.06 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 54.59 | 45.93 |
Price Performance
Historical ComparisonAbout YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.